Jason A. Okazaki - Apr 29, 2024 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role
CEO and President, Director
Signature
/s/ John O. Gunderson, as Attorney-in-Fact
Stock symbol
ASMB
Transactions as of
Apr 29, 2024
Transactions value $
-$19,937
Form type
4
Date filed
5/1/2024, 04:05 PM
Previous filing
Apr 2, 2024
Next filing
May 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction ASMB Common Stock +Grant/Award $0 +4,166 +30.13% $0.00 17,992 Apr 29, 2024 Direct F1
transaction ASMB Common Stock -Sell -$19,937 -1,569 -8.72% $12.71 16,423 Apr 30, 2024 Direct F2, F3

Explanation of Responses:

Id Content
F1 Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On April 29, 2024, a performance-based vesting condition was achieved.
F2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The sale is mandated by an administrative rule adopted by the Compensation Committee of the Issuer's Board of Directors that requires the satisfaction of tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the reporting person.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.3851 to $12.8847, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.